Enviva Analyst Ratings
Enviva Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/03/2023 | 29.87% | RBC Capital | → $10 | Reiterates | Sector Perform → Sector Perform |
| 07/11/2023 | 159.74% | Citigroup | $32 → $20 | Maintains | Buy |
| 05/15/2023 | 29.87% | RBC Capital | $32 → $10 | Maintains | Sector Perform |
| 05/05/2023 | 224.68% | Raymond James | $55 → $25 | Maintains | Strong Buy |
| 05/04/2023 | 29.87% | Truist Securities | $40 → $10 | Downgrades | Buy → Sell |
| 04/05/2023 | 315.58% | Citigroup | $62 → $32 | Maintains | Buy |
| 04/05/2023 | 614.29% | Raymond James | $65 → $55 | Maintains | Strong Buy |
| 04/04/2023 | 419.48% | Truist Securities | $70 → $40 | Maintains | Buy |
| 04/04/2023 | 315.58% | Citigroup | $62 → $32 | Maintains | Buy |
| 03/03/2023 | 471.43% | JP Morgan | $61 → $44 | Maintains | Neutral |
| 03/02/2023 | 744.16% | Raymond James | $80 → $65 | Maintains | Strong Buy |
| 02/01/2023 | 809.09% | Truist Securities | $80 → $70 | Maintains | Buy |
| 11/29/2022 | 718.18% | RBC Capital | $76 → $63 | Maintains | Sector Perform |
| 10/20/2022 | 679.22% | JP Morgan | $66 → $60 | Maintains | Neutral |
| 10/18/2022 | 938.96% | Raymond James | → $80 | Upgrades | Outperform → Strong Buy |
| 10/14/2022 | 705.19% | Citigroup | $79 → $62 | Upgrades | Neutral → Buy |
| 09/15/2022 | 938.96% | Raymond James | → $80 | Upgrades | Market Perform → Outperform |
| 08/19/2022 | 887.01% | RBC Capital | $78 → $76 | Downgrades | Outperform → Sector Perform |
| 07/20/2022 | 822.08% | JP Morgan | $70 → $71 | Maintains | Neutral |
| 05/13/2022 | 912.99% | RBC Capital | $85 → $78 | Maintains | Outperform |
| 04/19/2022 | 900% | JP Morgan | $76 → $77 | Maintains | Neutral |
| 04/05/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/29/2022 | 1198.7% | Truist Securities | → $100 | Initiates Coverage On | → Buy |
| 03/07/2022 | 1003.9% | RBC Capital | $78 → $85 | Maintains | Outperform |
| 03/02/2022 | 887.01% | JP Morgan | $70 → $76 | Maintains | Neutral |
| 01/04/2022 | 900% | Raymond James | $75 → $77 | Maintains | Outperform |
| 12/09/2021 | 900% | JP Morgan | → $77 | Downgrades | Overweight → Neutral |
| 11/05/2021 | 874.03% | Raymond James | $57 → $75 | Maintains | Outperform |
| 10/18/2021 | 938.96% | Barclays | $67 → $80 | Maintains | Overweight |
| 10/18/2021 | 874.03% | RBC Capital | $60 → $75 | Maintains | Outperform |
| 10/05/2021 | 640.26% | Raymond James | → $57 | Downgrades | Strong Buy → Outperform |
| 09/07/2021 | 718.18% | JP Morgan | → $63 | Initiates Coverage On | → Overweight |
| 09/02/2021 | 601.3% | Goldman Sachs | → $54 | Initiates Coverage On | → Neutral |
| 06/07/2021 | 744.16% | Barclays | $64 → $65 | Maintains | Overweight |
| 02/25/2021 | 640.26% | Raymond James | $52 → $57 | Maintains | Strong Buy |
| 01/08/2021 | 575.32% | Raymond James | $48 → $52 | Maintains | Strong Buy |
| 11/05/2020 | 523.38% | Raymond James | $44 → $48 | Maintains | Strong Buy |
| 10/08/2020 | 471.43% | Raymond James | $42 → $44 | Maintains | Strong Buy |
| 06/24/2020 | 445.45% | Raymond James | $38 → $42 | Maintains | Strong Buy |
| 04/30/2020 | 393.51% | Raymond James | $36 → $38 | Maintains | Strong Buy |
| 04/24/2020 | 354.55% | Citigroup | $40 → $35 | Maintains | Neutral |
| 03/18/2020 | 419.48% | Raymond James | → $40 | Upgrades | Outperform → Strong Buy |
| 02/13/2020 | 419.48% | Citigroup | $34 → $40 | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/03/2023 | 29.87% | 加拿大皇家银行资本 | →$10 | 重申 | 扇区表现→扇区表现 |
| 07/11/2023 | 159.74% | 花旗集团 | $32→$20 | 维护 | 买 |
| 2023年05月15日 | 29.87% | 加拿大皇家银行资本 | $32→$10 | 维护 | 行业表现 |
| 05/05/2023 | 224.68% | 雷蒙德·詹姆斯 | $55→$25 | 维护 | 强势购买 |
| 05/04/2023 | 29.87% | Truist证券 | $40→$10 | 评级下调 | Buy→Sell |
| 04/05/2023 | 315.58% | 花旗集团 | $62→$32 | 维护 | 买 |
| 04/05/2023 | 614.29% | 雷蒙德·詹姆斯 | $65→$55 | 维护 | 强势购买 |
| 04/04/2023 | 419.48% | Truist证券 | $70→$40 | 维护 | 买 |
| 04/04/2023 | 315.58% | 花旗集团 | $62→$32 | 维护 | 买 |
| 03/03/2023 | 471.43% | 摩根大通 | $61→$44 | 维护 | 中性 |
| 03/02/2023 | 744.16% | 雷蒙德·詹姆斯 | $80→$65 | 维护 | 强势购买 |
| 02/01/2023 | 809.09% | Truist证券 | $80→$70 | 维护 | 买 |
| 2022年11月29日 | 718.18% | 加拿大皇家银行资本 | $76→$63 | 维护 | 行业表现 |
| 10/20/2022 | 679.22% | 摩根大通 | $66→$60 | 维护 | 中性 |
| 10/18/2022 | 938.96% | 雷蒙德·詹姆斯 | →$80 | 升级 | 跑赢→强势买入 |
| 10/14/2022 | 705.19% | 花旗集团 | $79→$62 | 升级 | 中性→购买 |
| 09/15/2022 | 938.96% | 雷蒙德·詹姆斯 | →$80 | 升级 | 市场表现优于→ |
| 2022年08月19日 | 887.01% | 加拿大皇家银行资本 | $78→$76 | 评级下调 | 跑赢→板块表现 |
| 07/20/2022 | 822.08% | 摩根大通 | $70→$71 | 维护 | 中性 |
| 2022年05月13日 | 912.99% | 加拿大皇家银行资本 | $85→$78 | 维护 | 跑赢大盘 |
| 04/19/2022 | 900% | 摩根大通 | $76→$77 | 维护 | 中性 |
| 04/05/2022 | - | 雷蒙德·詹姆斯 | 评级下调 | 跑赢→市场表现 | |
| 03/29/2022 | 1198.7% | Truist证券 | →$100 | 开始承保 | →购买 |
| 03/07/2022 | 1003.9% | 加拿大皇家银行资本 | $78→$85 | 维护 | 跑赢大盘 |
| 03/02/2022 | 887.01% | 摩根大通 | $70→$76 | 维护 | 中性 |
| 01/04/2022 | 900% | 雷蒙德·詹姆斯 | $75→$77 | 维护 | 跑赢大盘 |
| 12/09/2021 | 900% | 摩根大通 | →$77 | 评级下调 | 超重→中性 |
| 2021年11月05日 | 874.03% | 雷蒙德·詹姆斯 | $57→$75 | 维护 | 跑赢大盘 |
| 10/18/2021 | 938.96% | 巴克莱 | $67→$80 | 维护 | 超重 |
| 10/18/2021 | 874.03% | 加拿大皇家银行资本 | $60→$75 | 维护 | 跑赢大盘 |
| 10/05/2021 | 640.26% | 雷蒙德·詹姆斯 | →$57 | 评级下调 | 强势买入→跑赢大盘 |
| 09/07/2021 | 718.18% | 摩根大通 | →$63 | 开始承保 | →超重 |
| 09/02/2021 | 601.3% | 高盛 | →$54 | 开始承保 | →中性 |
| 06/07/2021 | 744.16% | 巴克莱 | $64→$65 | 维护 | 超重 |
| 02/25/2021 | 640.26% | 雷蒙德·詹姆斯 | $52→$57 | 维护 | 强势购买 |
| 01/08/2021 | 575.32% | 雷蒙德·詹姆斯 | $48→$52 | 维护 | 强势购买 |
| 11/05/2020 | 523.38% | 雷蒙德·詹姆斯 | $44→$48 | 维护 | 强势购买 |
| 10/08/2020 | 471.43% | 雷蒙德·詹姆斯 | $42→$44 | 维护 | 强势购买 |
| 06/24/2020 | 445.45% | 雷蒙德·詹姆斯 | $38→$42 | 维护 | 强势购买 |
| 04/30/2020 | 393.51% | 雷蒙德·詹姆斯 | $36→$38 | 维护 | 强势购买 |
| 04/24/2020 | 354.55% | 花旗集团 | $40→$35 | 维护 | 中性 |
| 03/18/2020 | 419.48% | 雷蒙德·詹姆斯 | →$40 | 升级 | 跑赢→强势买入 |
| 02/13/2020 | 419.48% | 花旗集团 | $34→$40 | 评级下调 | 购买→中性 |
What is the target price for Enviva (EVA)?
英杰华(Eviva)的目标价是多少？
The latest price target for Enviva (NYSE: EVA) was reported by RBC Capital on October 3, 2023. The analyst firm set a price target for $10.00 expecting EVA to rise to within 12 months (a possible 29.87% upside). 16 analyst firms have reported ratings in the last year.
加拿大皇家银行资本于2023年10月3日报道了Enviva(纽约证券交易所代码：EVA)的最新目标价。这家分析公司将目标价定为10.00美元，预计EVA将在12个月内升至(可能上涨29.87%)。过去一年，有16家分析公司公布了评级。
What is the most recent analyst rating for Enviva (EVA)?
分析师对Eviva的最新评级是多少？
The latest analyst rating for Enviva (NYSE: EVA) was provided by RBC Capital, and Enviva reiterated their sector perform rating.
加拿大皇家银行资本提供了对Enviva(纽约证券交易所股票代码：EVA)的最新分析师评级，Enviva重申了其行业表现评级。
When is the next analyst rating going to be posted or updated for Enviva (EVA)?
Enviva(EVA)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enviva was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Enviva的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Enviva的上一次评级是在2023年10月3日提交的，所以你应该预计下一次评级将在2024年10月3日左右的某个时候提供。
Is the Analyst Rating Enviva (EVA) correct?
分析师对Enviva(EVA)的评级正确吗？
While ratings are subjective and will change, the latest Enviva (EVA) rating was a reiterated with a price target of $0.00 to $10.00. The current price Enviva (EVA) is trading at is $7.70, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Enviva(EVA)评级被重申，目标价在0.00美元至10.00美元之间。英杰华(Enviva)目前的股价为7.70美元，在分析师的预测范围内。